As the US President Trump announced the potential tariffs policy in the coming period, the pharma stocks plunged by 3-4% today. India is a major medicine supplier to the US, so the potential tariffs announcement on imported medicines has significantly affected the Indian market. Aurobindo stock fell by 4% to 1094, Lupin fell by 3.33% to 1937, Sun Pharma tumbled by 2%, Natco Pharma fell by 3.27%, while Granules India fell by up to 3.5%. This tariff policy may increase the cost of production and affect the business of the Indian pharma industry.